Insights

Genomics Leadership Leverage Genomics’ strong academic pedigree and leadership in genomic prevention to position offerings as cutting-edge solutions for large healthcare systems seeking risk stratification, preventative care, and personalized screening programs.

Strategic Partnerships Target collaborations with major biopharma companies and contract research organizations that require population-scale genomic insights, real-world evidence, and enhanced drug discovery pipelines to accelerate development and market access.

Global Footprint Capitalize on the transatlantic presence across UK and US offices and US labs to tailor regional deployment, regulatory navigation, and data partnerships, offering scalable, cross-border genomic analytics and implementation support.

Scale and Resources Position readiness to support large datasets and enterprise clients given a mid-size but highly skilled team, with capabilities in data science, software engineering, and commercial strategy to deliver end-to-end genomic risk solutions.

Technology Stack Highlight robust tech infrastructure including Python-based analytics, cloud-enabled databases, and analytics tooling to reassure prospects about data security, scalability, and integration with existing enterprise platforms.

Genomics Tech Stack

Genomics uses 8 technology products and services including Power BI, PostgreSQL, Google Workspace, and more. Explore Genomics's tech stack below.

  • Power BI
    Business Intelligence
  • PostgreSQL
    Database
  • Google Workspace
    Email
  • Kubecost
    IT Infrastructure & Operations Management
  • UNIX Shell
    Operating Systems
  • Node.js
    Programming Languages
  • Cloudflare Bot Management
    Security
  • Slack
    Software Framework

Media & News

Genomics's Email Address Formats

Genomics uses at least 2 format(s):
Genomics Email FormatsExamplePercentage
First.Last@genomicsplc.comJohn.Doe@genomicsplc.com
68%
Last@genomicsplc.comDoe@genomicsplc.com
24%
FLast@genomicsplc.comJDoe@genomicsplc.com
6%
First@genomicsplc.comJohn@genomicsplc.com
2%

Frequently Asked Questions

What is Genomics's stock symbol?

Minus sign iconPlus sign icon
Genomics is a publicly traded company; the company's stock symbol is NEO.

What is Genomics's official website and social media links?

Minus sign iconPlus sign icon
Genomics's official website is genomics.com and has social profiles on LinkedInCrunchbase.

What is Genomics's SIC code NAICS code?

Minus sign iconPlus sign icon
Genomics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Genomics have currently?

Minus sign iconPlus sign icon
As of July 2026, Genomics has approximately 186 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: P. D.Chief Executive Officer: B. I.Chief Executive Officer: M. L.. Explore Genomics's employee directory with LeadIQ.

What industry does Genomics belong to?

Minus sign iconPlus sign icon
Genomics operates in the Biotechnology Research industry.

What technology does Genomics use?

Minus sign iconPlus sign icon
Genomics's tech stack includes Power BIPostgreSQLGoogle WorkspaceKubecostUNIX ShellNode.jsCloudflare Bot ManagementSlack.

What is Genomics's email format?

Minus sign iconPlus sign icon
Genomics's email format typically follows the pattern of First.Last@genomicsplc.com. Find more Genomics email formats with LeadIQ.

How much funding has Genomics raised to date?

Minus sign iconPlus sign icon
As of July 2026, Genomics has raised $135M in funding. The last funding round occurred on Jan 08, 2024 for $45M.

When was Genomics founded?

Minus sign iconPlus sign icon
Genomics was founded in 2014.
Genomics logo

Genomics

Biotechnology ResearchEngland, United Kingdom51-200 Employees

Genomics operates as a transatlantic technology-driven biotechnology firm focused on applying genomic information to health, with the goal of enabling preventative medicine and supporting drug discovery. It was founded in 2014 by four University of Oxford geneticists, including Sir Peter Donnelly and Gil McVean. The company maintains proprietary algorithms and databases that map small genome variations to thousands of biological measurements and disease outcomes, generating insights for populations and clinicians.

It collaborates with leading life sciences companies such as Novo Nordisk and Vertex. Headquartered in Oxford with offices in Cambridge and London, UK, and North Carolina, US, along with labs in Framingham, US, it brings together a multidisciplinary team to advance genomic prevention and personalized risk estimation for common diseases and cancers, enabling early interventions and tailored screening.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
NEO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $135M

    Genomics has raised a total of $135M of funding over 8 rounds. Their latest funding round was raised on Jan 08, 2024 in the amount of $45Mas a series_c.

  • $25M$50M

    Genomics's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $135M

    Genomics has raised a total of $135M of funding over 8 rounds. Their latest funding round was raised on Jan 08, 2024 in the amount of $45Mas a series_c.

  • $25M$50M

    Genomics's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.